HCPCS Level IIdrugActive
J9039
Injection, blinatumomab
BETOS: O1D
Effective: 2016-01-01
Referenced in 2 policies
Description
Injection, blinatumomab, 1 microgram
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Blincyto
Manufacturer
Amgen Inc
HCPCS Dosage
1 MCG
Billing Units
35.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.